Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 292, pseudogene (RN7SL292P)

Target
RN7SL292P
Molecular classification
Pseudogene, Non-coding RNA, 7SL RNA pseudogene, Processed pseudogene
01

Overview

RNA, 7SL, cytoplasmic 292, pseudogene (RN7SL292P) is a human **pseudogene** that is part of a large family of non-coding RNAs derived from the 7SL RNA gene, which encodes the RNA component of the **signal recognition particle (SRP)** complex[1][3][6]. The functional 7SL RNA is essential for directing newly synthesized proteins to the endoplasmic reticulum by pausing translation and targeting the ribosome-protein complex to the membrane, but RN7SL292P itself does **not encode any functional protein or RNA product** and is considered a "dead" genetic element[5][7][8]. Instead, like many pseudogenes, it likely arose from a process in which a functional RNA gene was reverse transcribed and reinserted into the genome, resulting in a sequence that no longer produces a functional product[7][8]. While some 7SL pseudogenes in general have been implicated in gene regulation or disease mechanisms as competitive endogenous RNAs, there is **no current evidence of any biological or disease-related role for RN7SL292P specifically**[4]. RN7SL292P is not a drug target, is not associated with any disease, and has no known impact on patient selection, therapy, or safety.

Other names
RN7SL292PRNA, 7SL, cytoplasmic 292, pseudogene
02

Biological functions

None (no known coding or regulatory function as a pseudogene)
03

Disease associations

None established for this specific pseudogene; however, some 7SL pseudogenes and other pseudogenes can act as gene expression regulators or molecular decoys in human disease broadly, but this is not specifically shown for RN7SL292P[4].

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 292, pseudogene (RN7SL292P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 292, pseudogene (RN7SL292P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call